Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FQAAR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,374
Award facts
- Contract value 100% obligated
- $9,373.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on November 6, 2025, for 52 milligram Mirena contraceptive systems valued at $9,373.86 under a firm fixed-price arrangement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is to be completed by December 1, 2025, with performance occurring at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499,999,999 ceiling and extends through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to support the Department of Defense's recurring pharmaceutical and medical supply needs across military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders for diverse pharmaceutical products, including specialty medications and medical consumables, positions the company as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FQAAR?
SPE2DB26FQAAR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FQAAR worth?
The government has obligated $9,374 on SPE2DB26FQAAR.
Is contract SPE2DB26FQAAR an order under another contract?
Yes. SPE2DB26FQAAR is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB26FQAAR competed?
The extent of competition for SPE2DB26FQAAR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award